Back to search
FDAFDA · Food and drugs·Recall number D-0348-2024

Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01

Published February 28, 2024 · Recall initiated: February 12, 2024

Summary

FDA records drug Class II recall D-0348-2024, published February 28, 2024 and initiated February 12, 2024. Recalling firm: Micro Labs Limited; Status: Ongoing; Reported quantity: 24,768 bottles; Lot: ZOAG043. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Out of specification for residual solvents.

What to do

Voluntary: Firm initiated · Letter

Get an email if CLOBAZAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CLOBAZAM
Manufacturer
Micro Labs Limited
Distributor
Nationwide in the USA
UPC
0342571316013
Lot
ZOAG043
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01 recalled?

Yes. FDA published recall D-0348-2024 on February 28, 2024. Reported hazard: CGMP Deviations: Out of specification for residual solvents.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CLOBAZAM. UPC: 0342571316013.